---
figid: PMC9424640__fonc-12-972984-g007
figtitle: 'Therapeutic potential of NR4A1 in cancer: Focus on metabolism'
organisms:
- NA
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC9424640
filename: fonc-12-972984-g007.jpg
figlink: /pmc/articles/PMC9424640/figure/f7/
number: F7
caption: The roles of NR4A1 in regulating T cell. In AML, the inhibition of COX2/NR4A1/CTNNB1
  signaling pathway can increase the produce of CD8+ T cell to rescue anti-cancer
  immunity. In melanoma, β-AR agonist inhibits NR4A1 and its downstream glycolysis
  to mediate CD8+T cell activity.
papertitle: 'Therapeutic potential of NR4A1 in cancer: Focus on metabolism.'
reftext: Shan Deng, et al. Front Oncol. 2022;12:972984.
year: '2022'
doi: 10.3389/fonc.2022.972984
journal_title: Frontiers in Oncology
journal_nlm_ta: Front Oncol
publisher_name: Frontiers Media S.A.
keywords: metabolic reprogramming | NR4A1 | cancers | signaling pathways | tumor cells
automl_pathway: 0.951441
figid_alias: PMC9424640__F7
figtype: Figure
redirect_from: /figures/PMC9424640__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9424640__fonc-12-972984-g007.html
  '@type': Dataset
  description: The roles of NR4A1 in regulating T cell. In AML, the inhibition of
    COX2/NR4A1/CTNNB1 signaling pathway can increase the produce of CD8+ T cell to
    rescue anti-cancer immunity. In melanoma, β-AR agonist inhibits NR4A1 and its
    downstream glycolysis to mediate CD8+T cell activity.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - COX2
  - PTGS2
  - MTCO2P12
  - CD34
  - FCGR1BP
  - MSC
  - SLC25A37
  - CD8A
  - CD8B
  - NR4A1
  - HNF4A
  - ADRB2
  - NR1H4
  - BFAR
  - TRBV20OR9-2
  - TRA
  - TRB
  - TRD
  - TRG
  - cd34
  - msc
  - nr4a1
  - elk4
---
